Company news

Diaceutics Plc (LSE:DXRX) news

Diaceutics Plc news releases on 6ix. Latest, Jun 7, 2022: New AI and ML Capabilities Enhance DXRX Platform

View Diaceutics Plc →

Press releases — page 3

New AI and ML Capabilities Enhance DXRX Platform

June 7, 2022

Share Options and PDMR Shareholdings

May 27, 2022

Contract Win

May 5, 2022

Conversion of Convertible Loan Notes & TVR

April 5, 2022

Notice of 2021 Full Year Results

March 22, 2022

Confirmation of Directorate Change

March 18, 2022

Approval by CMS for enhanced data access

March 16, 2022

Investor Presentation

February 21, 2022

Contract with leading life sciences company

February 14, 2022

Directorate Change

January 11, 2022

Test Signal Launch and Contract Wins

December 9, 2021

Purchase/Transfer of Shares and PDMR Shareholdings

September 28, 2021

Nominated as finalists for Health Tech Awards 2021

September 21, 2021

DXRX Platform Contract Win

September 13, 2021

Two new experts join the Diaceutics Advisory Panel

September 8, 2021

Notice of Investor Presentation

August 31, 2021

Trading Update

July 8, 2021

Issue of Share Options and PDMR Shareholdings

July 1, 2021

New Contract Wins

June 24, 2021

Capital Markets Day and KPI Update

June 16, 2021

Notice of Capital Markets Day

June 7, 2021

Presenting data on COVID impact on cancer at ASCO

June 4, 2021

Change of Adviser

May 21, 2021

LGC SeraCare Partnership

May 13, 2021

Sale of Shares and PDMR Shareholding

May 12, 2021

Sale of Shares and Director/PDMR Shareholding

May 4, 2021

Share Incentive Plan

April 30, 2021

Notice of AGM and posting of Annual Report

April 21, 2021

New Vice President of Operations in Asia

April 12, 2021

Transfer of Shares and Director/PDMR Shareholding

April 8, 2021

COVID-19 Testing Data licensing agreement

April 1, 2021

New lease agreement and related party transaction

March 30, 2021

New Vice President of Finance appointment

March 4, 2021

Quarterly media update

January 21, 2021

Trading update

January 11, 2021

Diaceutics : Appoints Seasoned Business Leader Deborah Davis as Non-executive Chair

December 22, 2020

Diaceutics : and Alva10 partnership to deliver value-based test reimbursement model for US payers, pharma and testing providers via DXRX platform

November 30, 2020

European international award win

November 17, 2020

Commercial launch of DXRX

October 28, 2020

Diaceutics : Partners With Global EQA Providers to Implement Best-in-class Testing Standards

September 28, 2020

Diaceutics : Unveils Expert Advisory Panel Powering its Industry-Changing Diagnostic Network DXRX

September 14, 2020

Second Price Monitoring Extn

September 7, 2020

New contract win for DXRX platform

July 22, 2020

Diaceutics : Partners With Targos and HistoCyte Laboratories to Drive Global Diagnostic Testing Standardization

July 14, 2020

Price Monitoring Extension

July 6, 2020

Issue of Share Options

July 3, 2020

Result of General Meeting

June 29, 2020

Exercise of warrant

June 11, 2020

AGM Statement

May 19, 2020

Diagnostic network for precision medicine update

May 18, 2020

← Newer · Older →